Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 1/2022

01-01-2022 | Correction

Correction to: Infantile fibrosarcoma with TPN3-NTRK3 fusion in a boy with Bloom Syndrome

Authors: Sue M. Huson, Timo Staab, Marta Pereira, Heather Ward, Roberto Paredes, D. Gareth Evans, Daniel Baumhoer, James O’Sullivan, Ed Cheesman, Detlev Schindler, Stefan Meyer

Published in: Familial Cancer | Issue 1/2022

Login to get access

Excerpt

In the original article it was not clear that the senior authorship of this report is shared by D Schindler and S Meyer, reflecting the contributions made. The senior authorship should now be recognised as being shared. …
Metadata
Title
Correction to: Infantile fibrosarcoma with TPN3-NTRK3 fusion in a boy with Bloom Syndrome
Authors
Sue M. Huson
Timo Staab
Marta Pereira
Heather Ward
Roberto Paredes
D. Gareth Evans
Daniel Baumhoer
James O’Sullivan
Ed Cheesman
Detlev Schindler
Stefan Meyer
Publication date
01-01-2022
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2022
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00223-z

Other articles of this Issue 1/2022

Familial Cancer 1/2022 Go to the issue

Short Communication

Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant

Original Article

Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes

Review

Genetic predisposition to prostate cancer: an update

Review

Managing gastric cancer risk in lynch syndrome: controversies and recommendations

Original Article

Approach to screening for Familial Adenomatous Polyposis (FAP) in a cohort of 226 patients with Desmoid-type Fibromatosis (DF): experience of a specialist center in the UK

Original Article

Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits